Kulkarni Samarth's Form 4 filing
CRISPR Therapeutics AG (CRSP) · filed Mar 18, 2024
- Accession no.
- 0000950170-24-032989
- Filed
- Mar 18, 2024
- Trade date
- Mar 15, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.45M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kulkarni SamarthCIK 0001682019 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Common Shares | MOption exerciseAcquired | +20,000 | $19.12 | +$382,400 | 228,122 | Direct | |
| Mar 15, 2024 | Common Shares | SSaleDisposed | −10,613 | $71.97 | −$763,817.61 | 217,509 | Direct | |
| Mar 15, 2024 | Common Shares | SSaleDisposed | −9,387 | $73.06 | −$685,814.22 | 208,122 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Common Shares | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 19,582 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.